Skip to Main Content

Paper Details

Real-World Treatment Patterns and Outcomes Among Patients with Basal Cell Carcinoma Following First-Line Hedgehog Inhibitor Discontinuation.
Dermatol Ther (Heidelb)
0
2022
Author NameAffiliation
Asieh GolozarRegeneron Pharmaceuticals, Inc.
  • 1 - 1

Datasets

Release 1.2